“…The prodrug was safe and well tolerated across all dosing regimens. Significant changes in vital signs were not observed in this trial, despite the previously reported blood pressure elevation in response to topical application of FP agonists [41] and the association of tocolytic medication with hypotensive effects [42,43]. After oral administration, the prodrug was readily transformed into its metabolite OBE002.…”
Administration of OBE022 was safe and had favourable pharmacokinetic characteristics and no clinically relevant interaction with food. Our results allow further investigation of OBE022 in preterm labour patients.
“…The prodrug was safe and well tolerated across all dosing regimens. Significant changes in vital signs were not observed in this trial, despite the previously reported blood pressure elevation in response to topical application of FP agonists [41] and the association of tocolytic medication with hypotensive effects [42,43]. After oral administration, the prodrug was readily transformed into its metabolite OBE002.…”
Administration of OBE022 was safe and had favourable pharmacokinetic characteristics and no clinically relevant interaction with food. Our results allow further investigation of OBE022 in preterm labour patients.
“…[10] We evaluated the acute effects of therapeutic doses of ritodrine and atosiban on blood pressure, cardiac function, micro-circulation (total peripheral resistance) and macro-circulation (large artery stiffness) in healthy non-pregnant female volunteers.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.